Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8623 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8434 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8402 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8393 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8343 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8323 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8301 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8274 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8225 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8171 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8125 |
Intermediate Similarity |
NPD1653 |
Approved |
0.811 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8059 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8046 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8037 |
Intermediate Similarity |
NPD37 |
Approved |
0.8023 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8023 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7939 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7929 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7829 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7818 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7765 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD5403 |
Approved |
0.773 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7644 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7628 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7614 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7611 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7597 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7597 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7594 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7561 |
Intermediate Similarity |
NPD1512 |
Approved |
0.756 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7529 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD447 |
Suspended |
0.75 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7452 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7442 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7439 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7433 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7362 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7346 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7321 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7284 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD919 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7216 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7186 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7168 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7166 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7128 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7117 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD2797 |
Approved |
0.711 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7104 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7073 |
Intermediate Similarity |
NPD5762 |
Approved |
0.707 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7053 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7053 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD6032 |
Approved |
0.701 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD3268 |
Approved |
0.6995 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1357 |
Approved |
0.6988 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6975 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD1535 |
Discovery |
0.6959 |
Remote Similarity |
NPD3687 |
Approved |
0.6959 |
Remote Similarity |
NPD3686 |
Approved |
0.6951 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD17 |
Approved |
0.6941 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD7584 |
Approved |
0.6928 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6927 |
Remote Similarity |
NPD5242 |
Approved |
0.6923 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6914
|
Remote Similarity |
NPD5353 |
Approved |